2025 fourth_quarter Filing
Q4Income
$10K
Filed
January 20, 2026
Lobbying Activities
Health IssuesView all
advocacy and education around the company's value proposition to advance medicines to break the cycle of alcohol and drug dependence.
Contacted:Executive Office of the President (EOP), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (2)
MARK F LINDSAY
U.S House Staff
ERIK DELL